Colorcon

Colorcon Announces New On-Tablet Laser Inscription Technology to Protect Patients and Prevent Counterfeiting

WEST POINT, Pa., Aug. 1, 2007 (PRIME NEWSWIRE) -- Colorcon, a world leader in solid-dose design, formulation and tablet identification technologies, announces the intent of its Brand Enhancement Services Team to commercialize a new method to help pharmaceutical and nutritional supplement companies protect their brands from counterfeiting, prevent medication error, improve tablet traceability, and ultimately protect patients. The method incorporates a new on-tablet laser inscription technique, DataLase Pharmamark(TM), licensed from DataLase, to be used on film coated tablets. The film coatings will include a proprietary additive that induces a color change in the film coating precisely at locations on the tablet surface exposed to a low-power, DataLase-approved CO2 laser. The technique can facilitate identification control of every single tablet, from the time it leaves the manufacturing plant to the time the patient takes it.

Syndicate content